The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Germline Mutations in HOXB13 and Prostate-Cancer Risk
Open accessAbstract
BACKGROUND: Family history is a significant risk factor for prostate cancer, although the molecular basis for this association is poorly understood. Linkage studies have implicated chromosome 17q21-22 as a possible location of a prostate-cancer susceptibility gene. METHODS: We screened more than 200 genes in the 17q21-22 region by sequencing germline DNA from 94 unrelated patients with prostate cancer from families selected for linkage to the candidate region. We tested family members, additional case subjects, and control subjects to characterize the frequency of the identified mutations. RESULTS: Probands from four families were discovered to have a rare but recurrent mutation (G84E) in HOXB13 (rs138213197), a homeobox transcription factor gene that is important in prostate development. All 18 men with prostate cancer and available DNA in these four families carried the mutation. The carrier rate of the G84E mutation was increased by a factor of approximately 20 in 5083 unrelated subjects of European descent who had prostate cancer, with the mutation found in 72 subjects (1.4%), as compared with 1 in 1401 control subjects (0.1%) (P=8.5x10(-7)). The mutation was significantly more common in men with early-onset, familial prostate cancer (3.1%) than in those with late-onset, nonfamilial prostate cancer (0.6%) (P=2.0x10(-6)). CONCLUSIONS: The novel HOXB13 G84E variant is associated with a significantly increased risk of hereditary prostate cancer. Although the variant accounts for a small fraction of all prostate cancers, this finding has implications for prostate-cancer risk assessment and may provide new mechanistic insights into this common cancer. (Funded by the National Institutes of Health and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A haplotype map of the human genome
The International HapMap Consortium (2005) · Nature · doi:10.1038/nature04226 · Cited by 5,858
Siegel, R., Ward, E., Brawley, O., & Jemal, A. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20121 · Cited by 4,070
Human non-synonymous SNPs: server and survey
Ramensky, V. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf493 · Cited by 2,280
Cancer Incidence in BRCA1 Mutation Carriers
Thompson, D. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.18.1358 · Cited by 1,096
Predicting the Effects of Amino Acid Substitutions on Protein Function
Ng, P. C., & Henikoff, S. (2006) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.7.080505.115630 · Cited by 978
Gudmundsson, J., Sulem, P., Steinthorsdottir, V., Bergthorsson, J. T., Thorleifsson, G., Manolescu, A., Rafnar, T., Gudbjartsson, D., Agnarsson, B. A., Baker, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2062 · Cited by 723
Xu, J., Zheng, S. L., Komiya, A., Mychaleckyj, J. C., Isaacs, S. D., Hu, J. J., Sterling, D., Lange, E. M., Hawkins, G. A., Turner, A., et al. (2002) · Nature Genetics · doi:10.1038/ng994 · Cited by 392
Self-citationSeven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology, Kote-Jarai, Z., The UK ProtecT Study Collaborators, T. A. P. C. B., The PRACTICAL Consortium, Olama, A. A. A., Giles, G. G., Severi, G., Schleutker, J., Weischer, M., Campa, D., et al. (2011) · Nature Genetics · doi:10.1038/ng.882 · Cited by 289
Self-citationDefining Roles for HOX and MEIS1 Genes in Induction of Acute Myeloid Leukemia
Thorsteinsdottir, U., Kroon, E., Jerome, L., Blasi, F., & Sauvageau, G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.224-234.2001 · Cited by 284
Haiman, C. A., Chen, G. K., Blot, W. J., Strom, S. S., Berndt, S. I., Kittles, R. A., Rybicki, B. A., Isaacs, W. B., Ingles, S. A., Stanford, J. L., et al. (2011) · Nature Genetics · doi:10.1038/ng.839 · Cited by 222
Self-citation
Cited by
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Mohler, J. L., Antonarakis, E. S., Armstrong, A. J., D’Amico, A. V., Davis, B. J., Dorff, T., Eastham, J. A., Enke, C. A., Farrington, T. A., Higano, C. S., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0023 · Cited by 1,532
Rebello, R. J., Oing, C., Knudsen, K. E., Loeb, S., Johnson, D. C., Reiter, R. E., Gillessen, S., Van der Kwast, T., & Bristow, R. G. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00243-0 · Cited by 1,090
Attard, G., Parker, C., Eeles, R. A., Schröder, F., Tomlins, S. A., Tannock, I., Drake, C. G., & de Bono, J. S. (2016) · The Lancet · doi:10.1016/s0140-6736(14)61947-4 · Cited by 905
A generalized linear mixed model association tool for biobank-scale data
Jiang, L., Zheng, Z., Fang, H., & Yang, J. (2021) · Nature Genetics · doi:10.1038/s41588-021-00954-4 · Cited by 706
Hampel, H., Bennett, R. L., Buchanan, A., Pearlman, R., & Wiesner, G. L. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.147 · Cited by 587
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Initiative, T. C. R. U. G. (. O. G.-O., Eeles, R. A., Bioresource, T. A. P. C., The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology, Collaborators, T. U. P. (. T. F. C. A. T. S., The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Olama, A. A. A., Benlloch, S., Saunders, E. J., Leongamornlert, D. A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2560 · Cited by 542
Self-citationBeyond PSA: The Next Generation of Prostate Cancer Biomarkers
Prensner, J. R., Rubin, M. A., Wei, J. T., & Chinnaiyan, A. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003180 · Cited by 472
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
Pomerantz, M. M., Li, F., Takeda, D. Y., Lenci, R., Chonkar, A., Chabot, M., Cejas, P., Vazquez, F., Cook, J., Shivdasani, R. A., et al. (2015) · Nature Genetics · doi:10.1038/ng.3419 · Cited by 470
Conti, D. V., Darst, B. F., Moss, L. C., Saunders, E. J., Sheng, X., Chou, A., Schumacher, F. R., Olama, A. A. A., Benlloch, S., Dadaev, T., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00748-0 · Cited by 462
Self-citationEpidemiology of prostate cancer in Asian countries
Kimura, T., & Egawa, S. (2018) · International Journal of Urology · doi:10.1111/iju.13593 · Cited by 411
Androgen Signaling in Prostate Cancer
Dai, C., Heemers, H., & Sharifi, N. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030452 · Cited by 406
Prostate cancer in young men: an important clinical entity
Salinas, C. A., Tsodikov, A., Ishak-Howard, M., & Cooney, K. A. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.91 · Cited by 304
Self-citationVickers, A. J., Ulmert, D., Sjoberg, D. D., Bennette, C. J., Bjork, T., Gerdtsson, A., Manjer, J., Nilsson, P. M., Dahlin, A., Bjartell, A., et al. (2013) · BMJ · doi:10.1136/bmj.f2023 · Cited by 282
Giri, V. N., Knudsen, K. E., Kelly, W. K., Cheng, H. H., Cooney, K. A., Cookson, M. S., Dahut, W., Weissman, S., Soule, H. R., Petrylak, D. P., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00046 · Cited by 275
Self-citationGenomic Markers in Prostate Cancer Decision Making
Cucchiara, V., Cooperberg, M. R., Dall’Era, M., Lin, D. W., Montorsi, F., Schalken, J. A., & Evans, C. P. (2018) · European Urology · doi:10.1016/j.eururo.2017.10.036 · Cited by 269
The genetic epidemiology of prostate cancer and its clinical implications
Eeles, R., Goh, C., Castro, E., Bancroft, E., Guy, M., Olama, A. A. A., Easton, D., & Kote-Jarai, Z. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2013.266 · Cited by 260
Ulz, P., Perakis, S., Zhou, Q., Moser, T., Belic, J., Lazzeri, I., Wölfler, A., Zebisch, A., Gerger, A., Pristauz, G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12714-4 · Cited by 260
Wright, C. F., West, B., Tuke, M., Jones, S. E., Patel, K., Laver, T. W., Beaumont, R. N., Tyrrell, J., Wood, A. R., Frayling, T. M., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.12.015 · Cited by 212
Tumor suppressor p16 INK4A is necessary for survival of cervical carcinoma cell lines
McLaughlin-Drubin, M. E., Park, D., & Munger, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310432110 · Cited by 163
Influence of Androgens on Immunity to Self and Foreign: Effects on Immunity and Cancer
Ben-Batalla, I., Vargas-Delgado, M. E., von Amsberg, G., Janning, M., & Loges, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01184 · Cited by 149
“This finding was corroborated by a study of germline mutations, which identified one mutation in the homeobox transcription factor (HOXB13) known to interact with AR, leading to a 20-fold increased risk of inherited prostate cancer (122, 123).”
BackgroundGusev, A., Shi, H., Kichaev, G., Pomerantz, M., Li, F., Long, H. W., Ingles, S. A., Kittles, R. A., Strom, S. S., Rybicki, B. A., et al. (2016) · Nature Communications · doi:10.1038/ncomms10979 · Cited by 51
Das, R., Sjöström, M., Shrestha, R., Yogodzinski, C., Egusa, E. A., Chesner, L. N., Chen, W. S., Chou, J., Dang, D. K., Swinderman, J. T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24919-7 · Cited by 38
McLaughlin-Drubin, M., & Munger, K. (2013) · Viruses · doi:10.3390/v5051231 · Cited by 28
Mitchell, J., Camacho, N., Shea, P., Stopsack, K. H., Joseph, V., Burren, O. S., Dhindsa, R. S., Nag, A., Berchuck, J. E., O’Neill, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56944-1 · Cited by 19
Metadata
- Authors
- Ewing, C. M., Ray, A. M., Lange, E. M., Zuhlke, K. A., Robbins, C. M., Tembe, W. D., Wiley, K. E., Isaacs, S. D., Johng, D., Wang, Y., Bizon, C., Yan, G., Gielzak, M., Partin, A. W., Shanmugam, V., Izatt, T., Sinari, S., Craig, D. W., Zheng, S. L., Walsh, P. C., Montie, J. E., Xu, J., Carpten, J. D., Isaacs, W. B., & Cooney, K. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-01-12
- Volume
- 366
- Issue
- 2
- Pages
- 141-149
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2178232667
- Cited by
- 658
- References
- 31
- FWCI
- 43.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.